GPT and metabolic dysfunction-associated steatotic liver disease: A significantly greater proportion of individuals with NAFLD had elevated ALT (63.0% vs. 17.7%) and elevated GGT (57.6% vs. 13.3%) compared to those without NAFLD (p < 0.001 for both).